Carbon monoxide protects hepatocytes from TNF-alpha/Actinomycin D by inhibition of the caspase-8-mediated apoptotic pathway

Biochemical and Biophysical Research Communications
Hoe Suk KimBrian S Zuckerbraun

Abstract

We have previously shown that carbon monoxide (CO) (250 ppm) prevented tumor necrosis factor-alpha (TNFalpha)-induced apoptosis and activated the transcription factor NF-kappaB in hepatocytes both in vivo and in vitro. These studies were conducted to further determine the mechanisms by which CO suppresses apoptotic signaling in TNFalpha (10 ng/ml) and Actinomycin D (ActD, 200 ng/ml)-treated hepatocytes. Consistent with our previous findings, CO protected against TNFalpha/ActD-induced cell death, which is in part dependent on NF-kappaB activation. This was associated with a reduction in mitochondrial damage, a decrease in cytochrome c release, and an inhibition of translocation of Bcl proteins to mitochondria. In conjugation with inhibition of these mitochondrial events, CO also suppressed caspases-8 and -3 cleavage in response to TNFalpha/ActD. Inhibition of NF-kappaB activation resulted in diminished CO-induced cFLIP expression and increased caspase-8 cleavage from cells treated with TNFalpha/ActD. These data indicate that CO interferes with apoptotic signaling at a proximal step.

References

Jun 1, 1996·American Journal of Respiratory Cell and Molecular Biology·P J LeeA M Choi
Jan 7, 1998·The Journal of Cell Biology·K G WolterR J Youle
May 9, 1998·The Journal of Biological Chemistry·R TakahashiJ C Reed
Sep 12, 1998·Nature Medicine·M P SoaresF H Bach
Dec 18, 1998·International Journal of Molecular Medicine·W Durante, A I Schafer
Oct 4, 2000·The Journal of Experimental Medicine·S BrouardM P Soares
Jul 21, 2001·Molecular and Cellular Biology·O MicheauJ Tschopp
Feb 12, 2002·The Journal of Biological Chemistry·Kurt DegenhardtEileen White
Jul 2, 2002·American Journal of Respiratory Cell and Molecular Biology·Danielle Morse, Augustine M K Choi
Jul 19, 2002·Cardiovascular Research·Xiao-ming LiuWilliam Durante
Sep 7, 2002·The Journal of Biological Chemistry·Olivier MicheauMarkus G Grütter
Aug 12, 2003·Trends in Immunology·Leo E OtterbeinFritz H Bach
Sep 27, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gabriele SassGisa Tiegs
Oct 7, 2003·The Journal of Biological Chemistry·Qingding WangB Mark Evers
Dec 6, 2003·The Journal of Experimental Medicine·Brian S ZuckerbraunLeo E Otterbein
Mar 6, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Judit K SaradyLeo E Otterbein
Oct 16, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gabriele SassGisa Tiegs
May 14, 2005·American Journal of Physiology. Gastrointestinal and Liver Physiology·Brian S ZuckerbraunHenri R Ford
Jun 1, 2005·Free Radical Biology & Medicine·Nader G Abraham, Attallah Kappas
Jul 30, 2005·International Journal of Cancer. Journal International Du Cancer·Qingding WangB Mark Evers

❮ Previous
Next ❯

Citations

Mar 23, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·John D BelcherGregory M Vercellotti
Mar 11, 2011·BMC Cell Biology·Cláudia S F QueirogaHelena L A Vieira
Aug 2, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Daniel WysokinskiJacek Pawel Szaflik
Apr 27, 2012·Biochemistry Research International·Cláudia S F QueirogaHelena L A Vieira
Apr 6, 2017·American Journal of Hematology·Edward GompertsGregory M Vercellotti
Jan 16, 2010·International Journal of Toxicology·Jung-Hyun ParkKwan-Kyu Park
Feb 16, 2007·Cell Transplantation·Kimiaki TanakaNaoya Kobayashi
Mar 5, 2016·Chemical Communications : Chem Comm·Hiroyasu TabeTakafumi Ueno
Jul 26, 2019·FEMS Yeast Research·Cláudia Figueiredo-PereiraHelena L A Vieira
May 24, 2008·American Journal of Physiology. Gastrointestinal and Liver Physiology·Hoe Suk KimBrian S Zuckerbraun
Aug 15, 2018·International Journal of Molecular Sciences·Hyuk-Hoon Kim, Sangchun Choi
Jul 12, 2011·The American Journal of Pathology·Hyun-Ae EumTimothy R Billiar
Dec 17, 2009·Mitochondrion·Pamela B L PunShabbir Moochhala

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

© 2022 Meta ULC. All rights reserved